oleanolic acid has been researched along with chrysin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bohlin, L; Huss, U; Perera, P; Ringbom, T; Vasänge, M | 1 |
| Chin, YW; Jee, JG; Jeong, YJ; Keum, YS; Kim, Y; Lee, J; Lee, JM; Yu, MS | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Ahn, HC; Cho, SC; Choi, BY; Fei, X; Keum, YS; Kim, HJ; Lee, K; Seo, SY | 1 |
| Bailon-Moscoso, N; Castillo-Veintimilla, P; Romero-Benavides, JC; Ruano, AL; Silva-Rivas, R; Vivanco-Jaramillo, S | 1 |
| Akram, M; Atanasov, AG; Ateba, SB; Bachmann, F; Davis, RA; Engeli, RT; Krenn, L; Leugger, S; Njamen, D; Odermatt, A; Schuster, D; Stuppner, H; Temml, V; Vuorinen, A; Waltenberger, B | 1 |
| Fallarero, A; Hanski, L; Isojärvi, J; Karhu, E; Vuorela, P | 1 |
1 review(s) available for oleanolic acid and chrysin
| Article | Year |
|---|---|
Medicinal plants used as anthelmintics: Ethnomedical, pharmacological, and phytochemical studies.
Topics: Anthelmintics; Humans; Medicine, Traditional; Phytotherapy; Plants, Medicinal | 2017 |
6 other study(ies) available for oleanolic acid and chrysin
| Article | Year |
|---|---|
Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay.
Topics: Acrolein; Alkaloids; Animals; Anthraquinones; Aspirin; Biological Assay; Catalysis; Cinnamomum zeylanicum; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Eugenol; Flavonoids; Indomethacin; Inhibitory Concentration 50; Isoenzymes; Kinetics; Lactones; Models, Molecular; Nitrobenzenes; Oleanolic Acid; Plants, Medicinal; Prostaglandin-Endoperoxide Synthases; Pyrogallol; Steroids; Sulfonamides; Sulfones; Syzygium; Terpenes; Triterpenes; Ursolic Acid | 2002 |
Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13.
Topics: Adenosine Triphosphate; Antiviral Agents; Apigenin; Breast; Cell Line; Cell Proliferation; Colorimetry; DNA; DNA Helicases; Epithelial Cells; Female; Flavonoids; Fluorescence Resonance Energy Transfer; Hepacivirus; Humans; Hydrolysis; Inhibitory Concentration 50; Kinetics; Methyltransferases; RNA Helicases; Severe acute respiratory syndrome-related coronavirus; Species Specificity; Viral Nonstructural Proteins; Viral Proteins | 2012 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Discovery of α-mangostin as a novel competitive inhibitor against mutant isocitrate dehydrogenase-1.
Topics: Binding, Competitive; Drug Discovery; Humans; Isocitrate Dehydrogenase; MCF-7 Cells; Molecular Structure; Mutation; Recombinant Proteins; Structure-Activity Relationship; Xanthones | 2015 |
Potential Antiosteoporotic Natural Product Lead Compounds That Inhibit 17β-Hydroxysteroid Dehydrogenase Type 2.
Topics: 17-Hydroxysteroid Dehydrogenases; Biological Products; Enzyme Inhibitors; Etiocholanolone; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Testosterone | 2017 |
Identification of Privileged Antichlamydial Natural Products by a Ligand-Based Strategy.
Topics: Anti-Bacterial Agents; Azithromycin; Biological Products; Cell Line; Cell Survival; Chlamydophila pneumoniae; Drug Discovery; Humans; Ligands; Microbial Sensitivity Tests; Molecular Structure | 2017 |